{"id":"https://openalex.org/W7220678697","doi":"https://doi.org/10.1093/ofid/ofag631","title":"Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial","display_name":"Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7220678697","doi":"https://doi.org/10.1093/ofid/ofag631","pmid":"https://pubmed.ncbi.nlm.nih.gov/42921178","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13693481"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofag631","doi":"https://doi.org/10.1093/ofid/ofag631","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag631","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofag631","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076161042","display_name":"Ruth O. Adekunle","orcid":"https://orcid.org/0000-0001-5578-6571","observed_orcids":["https://orcid.org/0000-0001-5578-6571"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ruth O Adekunle","raw_affiliation_strings":["Medical University of South Carolina , Department of Medicine and Pediatrics, Division of Infectious Disease, Charleston, South Carolina ,"],"raw_orcid":"https://orcid.org/0000-0001-5578-6571","affiliations":[{"raw_affiliation_string":"Medical University of South Carolina , Department of Medicine and Pediatrics, Division of Infectious Disease, Charleston, South Carolina ,","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133330329","display_name":"Qian Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qian Wu","raw_affiliation_strings":["Case Western Reserve University , Department of Population and Quantitative Health Sciences, Cleveland, Ohio ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve University , Department of Population and Quantitative Health Sciences, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068374271","display_name":"Abdus Sattar","orcid":"https://orcid.org/0000-0003-3863-3113","observed_orcids":["https://orcid.org/0000-0003-3863-3113"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdus Sattar","raw_affiliation_strings":["Case Western Reserve University , Department of Population and Quantitative Health Sciences, Cleveland, Ohio ,"],"raw_orcid":"https://orcid.org/0000-0003-3863-3113","affiliations":[{"raw_affiliation_string":"Case Western Reserve University , Department of Population and Quantitative Health Sciences, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005542018","display_name":"Kianoush Ansari\u2010Gilani","orcid":"https://orcid.org/0000-0003-1605-6706","observed_orcids":["https://orcid.org/0000-0003-1605-6706"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kianoush Ansari-Gilani","raw_affiliation_strings":["University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112827955","display_name":"Danielle E. Labbato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Labbato","raw_affiliation_strings":["University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078177226","display_name":"Aaron A. Fletcher","orcid":"https://orcid.org/0009-0003-9837-9994","observed_orcids":["https://orcid.org/0009-0003-9837-9994"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron A Fletcher","raw_affiliation_strings":["University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,"],"raw_orcid":"https://orcid.org/0009-0003-9837-9994","affiliations":[{"raw_affiliation_string":"University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157760567","display_name":"Aidan D McComsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aidan D McComsey","raw_affiliation_strings":["Saint Ignatius High School , Cleveland, Ohio ,","University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Ignatius High School , Cleveland, Ohio ,","institution_ids":[]},{"raw_affiliation_string":"University Hospitals Cleveland Medical Center , Department of Medicine, Division of Infectious Disease, Cleveland, Ohio ,","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060287190","display_name":"Allison Ross Eckard","orcid":"https://orcid.org/0000-0002-3069-7721","observed_orcids":["https://orcid.org/0000-0002-3069-7721"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Allison Ross Eckard","raw_affiliation_strings":["Medical University of South Carolina , Department of Medicine and Pediatrics, Division of Infectious Disease, Charleston, South Carolina ,"],"raw_orcid":"https://orcid.org/0000-0002-3069-7721","affiliations":[{"raw_affiliation_string":"Medical University of South Carolina , Department of Medicine and Pediatrics, Division of Infectious Disease, Charleston, South Carolina ,","institution_ids":["https://openalex.org/I153297377"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5060287190","https://openalex.org/A5076161042"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75356971,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"10","first_page":"ofag631","last_page":"ofag631"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9440000057220459},{"id":"https://openalex.org/keywords/people-living-with-hiv","display_name":"people living with HIV","score":0.8180000185966492},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.843999981880188},{"id":"https://openalex.org/keywords/weight-regain","display_name":"weight regain","score":0.4860000014305115},{"id":"https://openalex.org/keywords/visceral-adipose-tissue","display_name":"visceral adipose tissue","score":0.9580000042915344},{"id":"https://openalex.org/keywords/body-fat","display_name":"fat mass","score":0.4390000104904175},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9110000133514404},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8759999871253967},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cardiometabolic-risk","display_name":"cardiometabolic risk","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9276999831199646},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8557000160217285},{"id":"https://openalex.org/C2776193436","wikidata":"https://www.wikidata.org/wiki/Q236232","display_name":"Waist","level":3,"score":0.614300012588501},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5740000009536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5472000241279602},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4896000027656555},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.4489000141620636},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4259999990463257},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41999998688697815},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3982999920845032},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.36640000343322754},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.3614000082015991},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.3093000054359436},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.2989000082015991},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2939999997615814},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27959999442100525},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.26829999685287476},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.2581000030040741},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.25679999589920044}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofag631","doi":"https://doi.org/10.1093/ofid/ofag631","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag631","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13693481","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13693481/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13693481/pdf/ofag631.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"},{"id":"pmid:42921178","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42921178","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open forum infectious diseases","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofag631","doi":"https://doi.org/10.1093/ofid/ofag631","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag631","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2186341741","display_name":"Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy","funder_award_id":"R01DK121619","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G9000856582","display_name":"Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health)","funder_award_id":"UM1TR004528","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000895734","display_name":"Georgia Clinical & Translational Science Alliance (Georgia CTSA)","funder_award_id":"UL1TR002378","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000915289","display_name":"J. NRSA Training Core","funder_award_id":"TL1TR002382","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220678697.pdf","grobid_xml":"https://content.openalex.org/works/W7220678697.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1998552927","https://openalex.org/W3138431202","https://openalex.org/W4224218205","https://openalex.org/W4400178611","https://openalex.org/W4410816805","https://openalex.org/W4412496135","https://openalex.org/W4416771997"],"related_works":["https://openalex.org/W4400178611","https://openalex.org/W4389029501","https://openalex.org/W4416771997","https://openalex.org/W4388759362","https://openalex.org/W4408667213","https://openalex.org/W4415891142","https://openalex.org/W4400178622","https://openalex.org/W7213456532","https://openalex.org/W4206691718","https://openalex.org/W7162526338"],"abstract_inverted_index":{"Background:":[0],"Human":[1],"immunodeficiency":[2],"virus":[3],"(HIV)-associated":[4],"lipohypertrophy":[5,226],"is":[6,15,57,132,246],"characterized":[7],"by":[8,82,115,185],"excess":[9],"central":[10],"and":[11,14,39,87,107,131,145,175,182,189,201,236],"visceral":[12,176],"adiposity":[13],"associated":[16],"with":[17,23,68,210,225],"increased":[18],"cardiometabolic":[19],"risk":[20],"among":[21],"people":[22],"HIV":[24],"(PWH).":[25],"In":[26],"a":[27,62],"previously":[28,157],"reported":[29],"randomized":[30,73],"trial,":[31],"semaglutide":[32,75,99,160,222],"significantly":[33],"reduced":[34],"body":[35,116,164,166,173,198],"weight,":[36,165,199,234],"regional":[37],"adiposity,":[38,235],"insulin":[40,190],"resistance":[41],"over":[42],"32":[43,79,181],"weeks":[44,180],"of":[45,51,84,98,221,231],"active":[46],"treatment.":[47],"However,":[48],"the":[49,142,153],"durability":[50],"these":[52],"benefits":[53],"after":[54],"treatment":[55],"discontinuation":[56,83],"unknown.":[58],"Methods:":[59],"We":[60],"conducted":[61],"randomized,":[63,139],"placebo-controlled":[64],"trial":[65,125],"in":[66,163,197,223,228,233],"PWH":[67,224],"HIV-associated":[69],"lipohypertrophy.":[70],"Participants":[71,156],"were":[72,119,204],"to":[74,105,159,249],"or":[76],"placebo":[77],"for":[78],"weeks,":[80],"followed":[81],"study":[85],"drug":[86],"observational":[88],"follow-up":[89],"through":[90],"week":[91,101,108,207],"56.":[92],"The":[93],"current":[94],"analysis":[95],"investigated":[96],"effects":[97],"at":[100,128,206],"56,":[102,183],"as":[103],"compared":[104,209],"baseline":[106],"32.":[109],"Outcomes":[110],"included":[111],"adipose":[112,177],"tissue":[113,178],"quantity":[114],"compartment.":[117],"Analyses":[118],"performed":[120],"using":[121],"intention-to-treat":[122],"principles.":[123],"This":[124],"was":[126],"registered":[127],"ClinicalTrials.gov":[129],"(NCT04019197)":[130],"complete.":[133],"Results:":[134],"Of":[135],"108":[136],"participants":[137,147,213],"initially":[138],"92":[140],"completed":[141,152],"32-week":[143],"intervention":[144],"80":[146],"(39":[148],"semaglutide,":[149],"41":[150],"placebo)":[151],"posttreatment":[154],"phase.":[155],"assigned":[158],"experienced":[161],"increases":[162],"mass":[167],"index":[168],"(BMI),":[169],"waist":[170,202],"circumference,":[171],"total":[172],"fat,":[174],"between":[179],"accompanied":[184],"worsening":[186],"glycemic":[187],"indices":[188],"resistance.":[191],"Despite":[192],"this":[193],"rebound,":[194],"net":[195],"reductions":[196],"BMI,":[200],"circumference":[203],"retained":[205],"56":[208],"baseline.":[211],"Placebo-treated":[212],"demonstrated":[214],"relative":[215],"stability":[216],"across":[217],"outcomes.":[218],"Conclusions:":[219],"Discontinuation":[220],"resulted":[227],"partial":[229],"loss":[230],"improvements":[232],"metabolic":[237],"parameters.":[238],"These":[239],"findings":[240],"support":[241],"that":[242],"sustained":[243],"pharmacologic":[244],"exposure":[245],"likely":[247],"needed":[248],"achieve":[250],"long-term":[251],"benefit.":[252]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-07T00:00:00"}
